TSE:4523Pharmaceuticals
What Eisai (TSE:4523)'s New Long‑Dated Bonds and UK Expansion Means For Shareholders
Earlier this month, Eisai Co., Ltd. issued three unsecured straight bond series totaling ¥50 billion, with fixed coupons of 2.226%, 2.614%, and 3.022% and maturities in 2031, 2033, and 2036, to fund research and development, licensed-in products, working capital, and refinance short-term debt.
A separate Eisai investment in the UK, supported by the government’s Life Sciences Innovation and Manufacturing Fund, enhances its research, development, and manufacturing footprint in oncology and...